{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:01Z","timestamp":1787020861159,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01621"],"award-info":[{"award-number":["PI19\/01621"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["2020111004"],"award-info":[{"award-number":["2020111004"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["2020333021"],"award-info":[{"award-number":["2020333021"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["2019222008"],"award-info":[{"award-number":["2019222008"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["2018222032"],"award-info":[{"award-number":["2018222032"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["2017222004"],"award-info":[{"award-number":["2017222004"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Diputacion Foral Gipuzkoa"},{"DOI":"10.13039\/501100005004","name":"Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["Elkartek"],"award-info":[{"award-number":["Elkartek"]}],"id":[{"id":"10.13039\/501100005004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphedema, the accumulation of interstitial fluid caused by poor lymphatic drainage, is a progressive and permanent disease with no curative treatment. Several studies have evaluated cell-based therapies in secondary lymphedema, but no meta-analysis has been performed to assess their efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of all available preclinical and clinical studies, with assessment of their quality and risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20 articles using diverse cell types were selected for analysis, including six clinical trials and 14 pre-clinical studies in three species. The meta-analysis showed a positive effect of cell-based therapies on relevant disease outcomes (quantification of edema, density of lymphatic capillaries, evaluation of the lymphatic flow, and tissue fibrosis). No significant publication bias was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cell-based therapies have the potential to improve secondary lymphedema. The underlying mechanisms remain unclear. Due to relevant heterogeneity between studies, further randomized controlled and blinded studies are required to substantiate the use of these novel therapies in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02632-y","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T05:02:49Z","timestamp":1637384569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Hector","family":"Lafuente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibon","family":"Jaunarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eukene","family":"Ansuategui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Lekuona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-7401","authenticated-orcid":false,"given":"Ander","family":"Izeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"issue":"2","key":"2632_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","volume":"182","author":"G Oliver","year":"2020","unstructured":"Oliver G, Kipnis J, Randolph GJ, Harvey NL. The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease. Cell. 2020;182(2):270\u201396.","journal-title":"Cell"},{"key":"2632_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.01.006","author":"OJ Manrique","year":"2020","unstructured":"Manrique OJ, Bustos SS, Ciudad P, Adabi K, Chen WF, Forte AJ, et al. Overview of lymphedema for physicians and other clinicians: a review of fundamental concepts. Mayo Clinic Proc. 2020; in press. https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.006.","journal-title":"Mayo Clinic Proc."},{"issue":"4","key":"2632_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/biology10040261","volume":"10","author":"B Brix","year":"2021","unstructured":"Brix B, Sery O, Onorato A, Ure C, Roessler A, Goswami N. Biology of lymphedema. Biology. 2021;10(4):261. https:\/\/doi.org\/10.3390\/biology10040261.","journal-title":"Biology"},{"issue":"22","key":"2632_CR4","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1002\/cncr.25458","volume":"116","author":"JN Cormier","year":"2010","unstructured":"Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138\u201349.","journal-title":"Cancer"},{"issue":"32","key":"2632_CR5","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2632_CR6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1191\/0269216305pm1020oa","volume":"19","author":"AF Williams","year":"2005","unstructured":"Williams AF, Franks PJ, Moffatt CJ. Lymphoedema: estimating the size of the problem. Palliat Med. 2005;19(4):300\u201313.","journal-title":"Palliat Med"},{"issue":"10","key":"2632_CR7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.molmed.2021.07.003","volume":"27","author":"S Stritt","year":"2021","unstructured":"Stritt S, Koltowska K, Makinen T. Homeostatic maintenance of the lymphatic vasculature. Trends Mol Med. 2021;27(10):955\u201370.","journal-title":"Trends Mol Med."},{"key":"2632_CR8","first-page":"21","volume-title":"Classification and staging of lymphedema. Lymphedema: diagnosis and treatment","author":"CL Morgan","year":"2008","unstructured":"Morgan CL, Lee BB. Classification and staging of lymphedema. Lymphedema: diagnosis and treatment. London: Springer London; 2008. p. 21\u201330."},{"key":"2632_CR9","doi-asserted-by":"crossref","first-page":"e20190074","DOI":"10.1590\/1677-5449.190074","volume":"19","author":"ML Brandao","year":"2020","unstructured":"Brandao ML, Soares H, Andrade MDA, Faria A, Pires RS. Efficacy of complex decongestive therapy for lymphedema of the lower limbs: a systematic review. J Vasc Bras. 2020;19:e20190074.","journal-title":"J Vasc Bras"},{"issue":"4","key":"2632_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cps.2020.06.012","volume":"47","author":"JB Tang","year":"2020","unstructured":"Tang JB, Landin L, Cavadas PC, Thione A, Chen J, Pons G, et al. Unique techniques or approaches in microvascular and microlymphatic surgery. Clin Plast Surg. 2020;47(4):649\u201361.","journal-title":"Clin Plast Surg"},{"issue":"3S Suppl 2","key":"2632_CR11","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1097\/SAP.0000000000002642","volume":"86","author":"K Chen","year":"2021","unstructured":"Chen K, Sinelnikov MY, Shchedrina MA, Mu L, Lu P. Surgical management of postmastectomy lymphedema and review of the literature. Ann Plastic Surg. 2021;86(3S Suppl 2):S173\u20136.","journal-title":"Ann Plastic Surg"},{"issue":"5","key":"2632_CR12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12282-021-01274-5","volume":"28","author":"K Gasteratos","year":"2021","unstructured":"Gasteratos K, Morsi-Yeroyannis A, Vlachopoulos NC, Spyropoulou GA, Del Corral G, Chaiyasate K. Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes. Breast Cancer (Tokyo, Japan). 2021;28(5):1002\u201315.","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"2632_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-060116-022900","volume":"69","author":"JH Dayan","year":"2018","unstructured":"Dayan JH, Ly CL, Kataru RP, Mehrara BJ. Lymphedema: pathogenesis and novel therapies. Annu Rev Med. 2018;69:263\u201376.","journal-title":"Annu Rev Med"},{"issue":"12","key":"2632_CR14","first-page":"e6269","volume":"11","author":"AJ Forte","year":"2019","unstructured":"Forte AJ, Boczar D, Huayllani MT, McLaughlin SA, Bagaria S. Topical approach to delivering targeted therapies in lymphedema treatment: a systematic review. Cureus. 2019;11(12):e6269.","journal-title":"Cureus"},{"issue":"6","key":"2632_CR15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00063030-200620060-00007","volume":"20","author":"L Cheung","year":"2006","unstructured":"Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, et al. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006;20(6):363\u201370.","journal-title":"BioDrugs"},{"issue":"11","key":"2632_CR16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/CIRCULATIONAHA.105.602953","volume":"114","author":"Y Saito","year":"2006","unstructured":"Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation. 2006;114(11):1177\u201384.","journal-title":"Circulation"},{"issue":"6","key":"2632_CR17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.RES.88.6.623","volume":"88","author":"B Enholm","year":"2001","unstructured":"Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res. 2001;88(6):623\u20139.","journal-title":"Circ Res"},{"issue":"6","key":"2632_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1084\/jem.20020587","volume":"196","author":"A Saaristo","year":"2002","unstructured":"Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med. 2002;196(6):719\u201330.","journal-title":"J Exp Med"},{"issue":"14","key":"2632_CR19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","volume":"16","author":"A Szuba","year":"2002","unstructured":"Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002;16(14):1985\u20137.","journal-title":"FASEB J"},{"issue":"11","key":"2632_CR20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.RES.0000168918.27576.78","volume":"96","author":"J Goldman","year":"2005","unstructured":"Goldman J, Le TX, Skobe M, Swartz MA. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circ Res. 2005;96(11):1193\u20139.","journal-title":"Circ Res"},{"issue":"1","key":"2632_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cts.12864","volume":"14","author":"K Chen","year":"2021","unstructured":"Chen K, Sinelnikov MY, Reshetov IV, Timashev P, Gu Y, Mu L, et al. Therapeutic potential of mesenchymal stem cells for postmastectomy lymphedema: a literature review. Clin Transl Sci. 2021;14(1):54\u201361.","journal-title":"Clin Transl Sci"},{"issue":"7","key":"2632_CR22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4252\/wjsc.v12.i7.612","volume":"12","author":"LR Hu","year":"2020","unstructured":"Hu LR, Pan J. Adipose-derived stem cell therapy shows promising results for secondary lymphedema. World J Stem Cells. 2020;12(7):612\u201320.","journal-title":"World J Stem Cells"},{"key":"2632_CR23","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane; 2021. Available from www.training.cochrane.org\/handbook."},{"key":"2632_CR24","unstructured":"Hooijmans CR, Wever KE, de Vries RBM. SYRCLEs starting guide for systematic reviews of preclinical animal interventions studies; 2016. Available from: www.radboudumc.nl\/getmedia\/4b1cbcb8-d9b6-45d5-b9fe-c92e43ab1dd4\/SYRCLE-starting-guide-tool.aspx."},{"issue":"5","key":"2632_CR25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Grup P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"key":"2632_CR26","doi-asserted-by":"crossref","first-page":"I4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:I4898.","journal-title":"BMJ"},{"key":"2632_CR27","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2632_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"2632_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hyn090","volume":"38","author":"C Hou","year":"2008","unstructured":"Hou C, Wu X, Jin X. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Jpn J Clin Oncol. 2008;38(10):670\u20134.","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"2632_CR30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3109\/14653249.2011.594791","volume":"13","author":"GEM Maldonado","year":"2011","unstructured":"Maldonado GEM, Perez CAA, Covarrubias EEA, Cabriales SAM, Leyva LA, Perez JCJ, et al. Autologous stem cells for the treatment of post-mastectomy lymphedema: A pilot study. Cytotherapy. 2011;13(10):1249\u201355.","journal-title":"Cytotherapy"},{"issue":"7","key":"2632_CR31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.5966\/sctm.2015-0357","volume":"5","author":"NM Toyserkani","year":"2016","unstructured":"Toyserkani NM, Jensen CH, Sheikh SP, Sorensen JA. Cell-assisted lipotransfer using autologous adipose-derived stromal cells for alleviation of breast cancer-related lymphedema. Stem Cells Transl Med. 2016;5(7):857\u20139.","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"2632_CR32","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/sctm.17-0037","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jensen CH, Andersen DC, Sheikh SP, Sorensen JA. Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafts: a feasibility and safety study. Stem Cells Transl Med. 2017;6(8):1666\u201372.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"2632_CR33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/lrb.2017.0027","volume":"16","author":"AM Ismail","year":"2018","unstructured":"Ismail AM, Abdou SM, Abdelnaby AY, Hamdy MA, El Saka AA, Gawaly A. Stem cell therapy using bone marrow-derived mononuclear cells in treatment of lower limb lymphedema: a randomized controlled clinical trial. Lymphat Res Biol. 2018;16(3):270\u20137.","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"2632_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bjps.2018.09.007","volume":"72","author":"NM Toyserkani","year":"2019","unstructured":"Toyserkani NM, Jensen CH, Tabatabaeifar S, Jorgensen MG, Hvidsten S, Simonsen JA, et al. Adipose-derived regenerative cells and fat grafting for treating breast cancer-related lymphedema: lymphoscintigraphic evaluation with 1 year of follow-up. J Plast Reconstr Aesthetic Surg. 2019;72(1):71\u20137.","journal-title":"J Plast Reconstr Aesthetic Surg."},{"issue":"2","key":"2632_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.108.793208","volume":"119","author":"C Conrad","year":"2009","unstructured":"Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation. 2009;119(2):281\u20139.","journal-title":"Circulation"},{"issue":"19","key":"2632_CR36","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1016\/j.biomaterials.2011.02.051","volume":"32","author":"JH Hwang","year":"2011","unstructured":"Hwang JH, Kim IG, Piao S, Lee DS, Lee TS, Ra JC, et al. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials. 2011;32(19):4415\u201323.","journal-title":"Biomaterials"},{"issue":"7","key":"2632_CR37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jjco\/hyr055","volume":"41","author":"H Zhou","year":"2011","unstructured":"Zhou H, Wang M, Hou C, Jin X, Wu X. Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema. Jpn J Clin Oncol. 2011;41(7):841\u20136.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"2632_CR38","doi-asserted-by":"crossref","first-page":"e000877","DOI":"10.1161\/JAHA.112.000877","volume":"1","author":"Y Shimizu","year":"2012","unstructured":"Shimizu Y, Shibata R, Shintani S, Ishii M, Murohara T. Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells. J Am Heart Assoc. 2012;1(4):e000877.","journal-title":"J Am Heart Assoc"},{"key":"2632_CR39","doi-asserted-by":"crossref","unstructured":"Park HS, Jung IM, Choi GH, Hahn S, Yoo YS, Lee T. Modification of a rodent hindlimb model of secondary lymphedema: Surgical radicality versus radiotherapeutic ablation. BioMed research international. 2013;2013 (no pagination)(208912).","DOI":"10.1155\/2013\/208912"},{"issue":"1","key":"2632_CR40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jss.2013.11.1116","volume":"189","author":"Y Kawai","year":"2014","unstructured":"Kawai Y, Shiomi H, Abe H, Naka S, Kurumi Y, Tani T. Cell transplantation therapy for a rat model of secondary lymphedema. J Surg Res. 2014;189(1):184\u201391.","journal-title":"J Surg Res"},{"key":"2632_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mvr.2015.09.001","volume":"102","author":"M Ackermann","year":"2015","unstructured":"Ackermann M, Wettstein R, Senaldi C, Kalbermatten DF, Konerding MA, Raffoul W, et al. Impact of platelet rich plasma and adipose stem cells on lymphangiogenesis in a murine tail lymphedema model. Microvasc Res. 2015;102:78\u201385.","journal-title":"Microvasc Res"},{"issue":"5","key":"2632_CR42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/rme.15.24","volume":"10","author":"S Yoshida","year":"2015","unstructured":"Yoshida S, Hamuy R, Hamada Y, Yoshimoto H, Hirano A, Akita S. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model. Regen Med. 2015;10(5):549\u201362.","journal-title":"Regen Med"},{"issue":"16","key":"2632_CR43","doi-asserted-by":"crossref","first-page":"e89081","DOI":"10.1172\/jci.insight.89081","volume":"1","author":"E Gousopoulos","year":"2016","unstructured":"Gousopoulos E, Proulx ST, Bachmann SB, Scholl J, Dionyssiou D, Demiri E, et al. Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function. JCI insight. 2016;1(16):e89081.","journal-title":"JCI insight"},{"issue":"3","key":"2632_CR44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/PRS.0000000000003110","volume":"139","author":"K Hayashida","year":"2017","unstructured":"Hayashida K, Yoshida S, Yoshimoto H, Fujioka M, Saijo H, Migita K, et al. Adipose-derived stem cells and vascularized lymph node transfers successfully treat mouse hindlimb secondary lymphedema by early reconnection of the lymphatic system and lymphangiogenesis. Plast Reconstr Surg. 2017;139(3):639\u201351.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2632_CR45","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1038\/s41598-018-21610-8","volume":"8","author":"M Beerens","year":"2018","unstructured":"Beerens M, Aranguren XL, Hendrickx B, Dheedene W, Dresselaers T, Himmelreich U, et al. Multipotent adult progenitor cells support lymphatic regeneration at multiple anatomical levels during wound healing and lymphedema. Sci Rep. 2018;8(1):3852.","journal-title":"Sci Rep"},{"issue":"5","key":"2632_CR46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/2000656X.2020.1772799","volume":"54","author":"A Bucan","year":"2020","unstructured":"Bucan A, Dhumale P, Jorgensen MG, Dalaei F, Wiinholt A, Hansen CR, et al. Comparison between stromal vascular fraction and adipose derived stem cells in a mouse lymphedema model. J Plast Surg Hand Surg. 2020;54(5):302\u201311.","journal-title":"J Plast Surg Hand Surg"},{"issue":"2","key":"2632_CR47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PRS.0000000000006474","volume":"145","author":"T Dai","year":"2020","unstructured":"Dai T, Jiang Z, Cui C, Sun Y, Lu B, Li H, et al. The roles of podoplanin-positive\/podoplanin-negative cells from adipose-derived stem cells in lymphatic regeneration. Plast Reconstr Surg. 2020;145(2):420\u201331.","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"2632_CR48","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.3390\/ijms21113885","volume":"21","author":"R Ogino","year":"2020","unstructured":"Ogino R, Hayashida K, Yamakawa S, Morita E. Adipose-derived stem cells promote intussusceptive lymphangiogenesis by restricting dermal fibrosis in irradiated tissue of mice. Int J Mol Sci. 2020;21(11):3885. https:\/\/doi.org\/10.3390\/ijms21113885.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2632_CR49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.25661","volume":"121","author":"CE Chen","year":"2020","unstructured":"Chen CE, Chiang NJ, Perng CK, Ma H, Lin CH. Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema. J Surg Oncol. 2020;121(1):109\u201320.","journal-title":"J Surg Oncol"},{"issue":"7","key":"2632_CR50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4252\/wjsc.v12.i7.676","volume":"12","author":"ZJ Li","year":"2020","unstructured":"Li ZJ, Yang E, Li YZ, Liang ZY, Huang JZ, Yu NZ, et al. Application and prospect of adipose stem cell transplantation in treating lymphedema. World J Stem Cells. 2020;12(7):676\u201387.","journal-title":"World J Stem Cells"},{"key":"2632_CR51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","volume":"221","author":"HM Vesterinen","year":"2014","unstructured":"Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods. 2014;221:92\u2013102.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"2632_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/lrb.2016.0015","volume":"15","author":"R Hadrian","year":"2017","unstructured":"Hadrian R, Palmes D. Animal models of secondary lymphedema: new approaches in the search for therapeutic options. Lymphat Res Biol. 2017;15(1):2\u201316.","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"2632_CR53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jss.2015.07.005","volume":"200","author":"FS Frueh","year":"2016","unstructured":"Frueh FS, Gousopoulos E, Rezaeian F, Menger MD, Lindenblatt N, Giovanoli P. Animal models in surgical lymphedema research\u2013a systematic review. J Surg Res. 2016;200(1):208\u201320.","journal-title":"J Surg Res"},{"issue":"13","key":"2632_CR54","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/ijms21134790","volume":"21","author":"YJ Lee","year":"2020","unstructured":"Lee YJ. Cell fate determination of lymphatic endothelial cells. Int J Mol Sci. 2020;21(13):4790. https:\/\/doi.org\/10.3390\/ijms21134790.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2632_CR55","first-page":"54","volume":"13","author":"C Zhou","year":"2020","unstructured":"Zhou C, Su W, Han H, Li N, Ma G, Cui L. Mouse tail models of secondary lymphedema: fibrosis gradually worsens and is irreversible. Int J Clin Exp Pathol. 2020;13(1):54\u201364.","journal-title":"Int J Clin Exp Pathol"},{"key":"2632_CR56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2019.00470","volume":"10","author":"RP Kataru","year":"2019","unstructured":"Kataru RP, Baik JE, Park HJ, Wiser I, Rehal S, Shin JY, et al. Regulation of immune function by the lymphatic system in lymphedema. Front Immunol. 2019;10:470.","journal-title":"Front Immunol"},{"key":"2632_CR57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2019.00076","volume":"10","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Arcucci V, Levy SM, Achen MG. Modulation of immunity by lymphatic dysfunction in lymphedema. Front Immunol. 2019;10:76.","journal-title":"Front Immunol"},{"issue":"6","key":"2632_CR58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/sctm.20-0394","volume":"10","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, Toyserkani NM, Jensen CH, Andersen DC, Sheikh SP, Sorensen JA. Adipose-derived regenerative cells and lipotransfer in alleviating breast cancer-related lymphedema: An open-label phase I trial with 4 years of follow-up. Stem Cells Transl Med. 2021;10(6):844\u201354.","journal-title":"Stem Cells Transl Med"},{"issue":"13","key":"2632_CR59","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood-2005-01-0226","volume":"106","author":"P Religa","year":"2005","unstructured":"Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005;106(13):4184\u201390.","journal-title":"Blood"},{"issue":"1","key":"2632_CR60","doi-asserted-by":"crossref","first-page":"e100115","DOI":"10.1136\/bmjos-2020-100115","volume":"4","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Sci. 2020;4(1):e100115.","journal-title":"BMJ Open Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02632-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T17:44:42Z","timestamp":1699811082000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02632-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2632"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02632-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]},"assertion":[{"value":"15 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}